BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1244914)

  • 41. Banding analysis of abnormal karyotypes in spontaneous abortion.
    Kajii T; Oama K; Niikawa N; Ferrier A; Avirachan S
    Am J Hum Genet; 1973 Sep; 25(5):539-47. PubMed ID: 4741848
    [No Abstract]   [Full Text] [Related]  

  • 42. Multiple myeloma in one of a pair of monozygotic twins.
    Ogawa M; Wurster DH; McIntyre OR
    Acta Haematol; 1970; 44(5):295-304. PubMed ID: 4994892
    [No Abstract]   [Full Text] [Related]  

  • 43. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytogenetic study of a Merkel cell carcinoma.
    Kusyk CJ; Romsdahl MM
    Cancer Genet Cytogenet; 1986 Feb; 20(3-4):311-6. PubMed ID: 3943069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of genetic abnormalities provides insights into genetic evolution of hyperdiploid myeloma.
    Chng WJ; Ketterling RP; Fonseca R
    Genes Chromosomes Cancer; 2006 Dec; 45(12):1111-20. PubMed ID: 16955468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cytogenetic studies in myeloma.
    Dartnall JA; Mundy GR; Baikie AG
    Blood; 1973 Aug; 42(2):229-39. PubMed ID: 4793112
    [No Abstract]   [Full Text] [Related]  

  • 47. Karyotype in multiple myeloma and plasma cell leukaemia.
    Weh HJ; Gutensohn K; Selbach J; Kruse R; Wacker-Backhaus G; Seeger D; Fiedler W; Fett W; Hossfeld DK
    Eur J Cancer; 1993; 29A(9):1269-73. PubMed ID: 8343266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Translocations involving chromosomes #3 and #12: hematologic diseases associated with abnormalities of these chromosomes.
    Sandberg AA; Hecht BK; Ondreyco SM; Prieto F; Hecht F
    Cancer Genet Cytogenet; 1982 Sep; 7(1):1-17. PubMed ID: 6754070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined morphological and interphase fluorescence in situ hybridization study in multiple myeloma of Chinese patients.
    Ng MH; Kan A; Chung YF; Wong IH; Lo KW; Wickham NW; Lei KI; Lee JC
    Am J Pathol; 1999 Jan; 154(1):15-22. PubMed ID: 9916913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytogenetic studies in polycythemia vera.
    Wurster-Hill D; Whang-Peng J; McIntyre OR; Hsu LY; Hirschhorn K; Modan B; Pisciotta AV; Pierre R; Balcerzak SP; Murphy S; Weinfeld A
    Semin Hematol; 1976 Jan; 13(1):13-32. PubMed ID: 1251221
    [No Abstract]   [Full Text] [Related]  

  • 51. Cytogenetic studies in multiple myeloma: a study of fourteen cases.
    Tassoni EM; Durant JR; Becker S; Kravitz B
    Cancer Res; 1967 Apr; 27(4):806-10. PubMed ID: 6025735
    [No Abstract]   [Full Text] [Related]  

  • 52. G banding analysis of complex aneuploidy in a case of erythroleukaemia.
    Philip P
    Scand J Haematol; 1976 May; 16(5):365-8. PubMed ID: 1065955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of fluorescence in situ hybridization for retrospective detection of aneuploidy in multiple myeloma.
    Lee W; Han K; Drut RM; Harris CP; Meisner LF
    Genes Chromosomes Cancer; 1993 Jul; 7(3):137-43. PubMed ID: 7687866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Whole-genome optical mapping of bone-marrow myeloma cells reveals association of extramedullary multiple myeloma with chromosome 1 abnormalities.
    Kriegova E; Fillerova R; Minarik J; Savara J; Manakova J; Petrackova A; Dihel M; Balcarkova J; Krhovska P; Pika T; Gajdos P; Behalek M; Vasinek M; Papajik T
    Sci Rep; 2021 Jul; 11(1):14671. PubMed ID: 34282158
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Selective endoreduplication of a supernumerary chromosome in a case of multiple myeloma (Kahler's disease)].
    de Grouchy J; de Nava C; Bilski-Pasquier G; Zittoun R; Bernadou A
    Ann Genet; 1967 Mar; 10(1):43-5. PubMed ID: 5300127
    [No Abstract]   [Full Text] [Related]  

  • 56. Cytogenetic data in 41 patients with multiple myeloma. Karyotype and other clinical parameters.
    Cigudosa JC; Calasanz MJ; Odero MD; Prosper F; Etxaniz A; Marin J; Rifón J; Gullón A; Rocha E
    Cancer Genet Cytogenet; 1994 Dec; 78(2):210-3. PubMed ID: 7828155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: cytologic and cytogenetic evidence in thirty-four patients.
    Cuneo A; Balsamo R; Roberti MG; Bardi A; Piva N; Balboni M; Bigoni R; Rigolin GM; Castoldi G
    Cancer Genet Cytogenet; 1996 Sep; 90(2):171-5. PubMed ID: 8830729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High frequencies of chromosomal aberrations in multiple myeloma and monoclonal gammopathy of undetermined significance in direct chromosome preparation.
    Nilsson T; Lenhoff S; Rylander L; Höglund M; Turesson I; Mitelman F; Westin J; Johansson B
    Br J Haematol; 2004 Aug; 126(4):487-94. PubMed ID: 15287940
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Banded karyotypes from bone marrow: a clinical useful approach.
    Hozier JC; Lindquist LL
    Hum Genet; 1980 Feb; 53(2):205-9. PubMed ID: 7358387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Karyotypic abnormalities and their clinical aspects in multiple myeloma.
    Scudla V; Jarosová M; Kapustová M; Indrák K; Smoldas J
    Acta Univ Palacki Olomuc Fac Med; 1991; 129():69-79. PubMed ID: 1837676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.